Monsanto’s German owner Bayer AG has failed in efforts to head off a Missouri trial over claims brought by cancer patients that Monsanto’s herbicide caused their diseases and Monsanto hid the risks. In a ruling handed down Wednesday, St. Louis City Judge Elizabeth Byrne Hogan…
Read MoreBayer has agreed to postpone two upcoming trials involving its Roundup weedkiller, citing ongoing settlement talks with plaintiffs. Bayer, which acquired Roundup in 2018 as part of its $63 billion purchase of St. Louis-based Monsanto Co., agreed to delay two trials that were set to begin in January in…
Read MoreBayer expects the number of claims in the United States related to Roundup herbicide to have surged in the third quarter, as the German drugs and pesticides maker tries to reach a settlement after earlier court rulings against it. “With the substantial increase in plaintiff…
Read MoreBy: Kim Russell In September 2017, Phil Corsi went to the doctor complaining about pain after eating. He got a diagnosis he never expected. “I had a large lymphoma that had become cancerous,” said Phil Corsi. His days became filled with doctor’s appointments and chemotherapy…
Read More